COLTS NECK, NJ, 17 January 2012 – Nextremity Solutions, Inc announced it has established Nextremity Solutions Europe GmbH in Jülich, Germany. The new subsidiary company will serve as the platform for launching Nextremity Solutions products in Germany and other key markets in Europe. The European launch of the NEXTRA ™ Hammertoe Correction System, the company’s first product, commenced last week with the first human implants. William von Brendel, VP & GM, International, commented, “We are excited to have a direct presence in the largest orthopaedic extremity market in Europe. Nextremity Solutions Europe will provide direct support to surgeons in private clinics and hospitals in treating the hammertoe deformity, a condition that is estimated to affect almost 100 million Europeans. NEXTRA is the first in a series of highly innovative surgical solutions for the foot and ankle market, one of the fastest growing sectors in the medical device industry.” About Nextremity Solutions, Inc. Nextremity Solutions is a privately held medical-device company offering a novel approach to the surgical correction of small bone deformity, degeneration and trauma, founded by surgeons who are committed to the development of medical implants that will provide repeatable and superior patient outcomes. Nextra™ Hammertoe Correction System and Nextra™ Hammertoe Correction Implant are trademarks of Nextremity Solutions, Inc. For further information, visit www.nextremitysolutions.com or call 574-635-3023.
